Synapticure
@synapticure.bsky.social
Cutting-edge telemedicine for patients with Alzheimer's and related Dementia, Parkinson’s, ALS and more. 🌐 synapticure.com | 📞(855) 255-5917
Look forward to seeing everyone shortly to meet with ALS patients who in @Neuralink's BCI study and learn how they're using it to today.
Register here to join or receive the video. vist.ly/4b2p8
Register here to join or receive the video. vist.ly/4b2p8
October 28, 2025 at 5:41 PM
Look forward to seeing everyone shortly to meet with ALS patients who in @Neuralink's BCI study and learn how they're using it to today.
Register here to join or receive the video. vist.ly/4b2p8
Register here to join or receive the video. vist.ly/4b2p8
Brain Computer Interfaces (BCI) has the chance to dramatically change care for ALS patients. We are grateful to host three patients in Neuralink's ALS trial for webinar on October 28th at 2PM ET with representatives from @neuralink.
register here: vist.ly/4bhnb
register here: vist.ly/4bhnb
October 23, 2025 at 4:41 PM
Brain Computer Interfaces (BCI) has the chance to dramatically change care for ALS patients. We are grateful to host three patients in Neuralink's ALS trial for webinar on October 28th at 2PM ET with representatives from @neuralink.
register here: vist.ly/4bhnb
register here: vist.ly/4bhnb
Synapticure is excited to share that we will be hosting a webinar on October 28, 2025 with participants in the @Neuralink ongoing ALS trial, along with representatives from the company.
The webinar will feature Brad Smith, Jake Schneider, and Nick Wray—three individuals with ALS
October 21, 2025 at 4:26 PM
Synapticure is excited to share that we will be hosting a webinar on October 28, 2025 with participants in the @Neuralink ongoing ALS trial, along with representatives from the company.
The webinar will feature Brad Smith, Jake Schneider, and Nick Wray—three individuals with ALS
Exciting news! Our CEO, Sandra Abrevaya, will keynote at New York Brain-Computer Interface Symposium (#NYBCI25) in NYC (Oct 3-4) on the power of advocacy in #BCI innovation.
September 9, 2025 at 3:52 PM
Exciting news! Our CEO, Sandra Abrevaya, will keynote at New York Brain-Computer Interface Symposium (#NYBCI25) in NYC (Oct 3-4) on the power of advocacy in #BCI innovation.
From virtual visits with leading specialists to wraparound care, medication management, genetic testing, counseling, and access to clinical trials— we make expert care available all from the comfort of your home.
Learn more at synapticure.com
#ALZ #ALS #PD
Learn more at synapticure.com
#ALZ #ALS #PD
August 28, 2025 at 6:27 PM
From virtual visits with leading specialists to wraparound care, medication management, genetic testing, counseling, and access to clinical trials— we make expert care available all from the comfort of your home.
Learn more at synapticure.com
#ALZ #ALS #PD
Learn more at synapticure.com
#ALZ #ALS #PD
Curious about genetic testing? You’re not alone.
Read our experts' insights on our blog.
Want to know if genetic testing is right for you? Call (855) 255-5917 to schedule a call with our experts.
#GeneticTesting #ClinicalTrials #Genetics
Read our experts' insights on our blog.
Want to know if genetic testing is right for you? Call (855) 255-5917 to schedule a call with our experts.
#GeneticTesting #ClinicalTrials #Genetics
August 26, 2025 at 3:52 PM
Curious about genetic testing? You’re not alone.
Read our experts' insights on our blog.
Want to know if genetic testing is right for you? Call (855) 255-5917 to schedule a call with our experts.
#GeneticTesting #ClinicalTrials #Genetics
Read our experts' insights on our blog.
Want to know if genetic testing is right for you? Call (855) 255-5917 to schedule a call with our experts.
#GeneticTesting #ClinicalTrials #Genetics
From one family’s journey to a national movement— our latest blog shares the story behind our mission and the care model we've built to support millions of families across country.
Read the full story here → vist.ly/446ui
#Alzheimers #ALS #Parkinsons #Dementia
Read the full story here → vist.ly/446ui
#Alzheimers #ALS #Parkinsons #Dementia
Synapticure’s Origin Story: Our Mission, Milestones, and Impact | Synapticure
After an ALS diagnosis at 37, Brian Wallach and Sandra Abrevaya founded Synapticure to fix a broken system. Learn how their personal story became a national model for virtual neurodegenerative care.
www.synapticure.com
August 21, 2025 at 9:44 PM
From one family’s journey to a national movement— our latest blog shares the story behind our mission and the care model we've built to support millions of families across country.
Read the full story here → vist.ly/446ui
#Alzheimers #ALS #Parkinsons #Dementia
Read the full story here → vist.ly/446ui
#Alzheimers #ALS #Parkinsons #Dementia
At the @alsassociation #ALSNexus, we were proud to highlight caregivers’ vital role in #ALSCare + share our fully remote #ClinicalTrial for #ALS. We're proud to stand with a community that won’t give up on better care, better treatments, and a better future.
August 19, 2025 at 8:56 PM
At the @alsassociation #ALSNexus, we were proud to highlight caregivers’ vital role in #ALSCare + share our fully remote #ClinicalTrial for #ALS. We're proud to stand with a community that won’t give up on better care, better treatments, and a better future.
Did you know that addressing mental health is a crucial, yet often unmet, need for those facing #neurodisorders? Our CoCM program ensures that emotional well-being is a core component of care.
Because true support is more than just treating symptoms 💙
vist.ly/43ry7
Because true support is more than just treating symptoms 💙
vist.ly/43ry7
August 18, 2025 at 6:27 PM
Did you know that addressing mental health is a crucial, yet often unmet, need for those facing #neurodisorders? Our CoCM program ensures that emotional well-being is a core component of care.
Because true support is more than just treating symptoms 💙
vist.ly/43ry7
Because true support is more than just treating symptoms 💙
vist.ly/43ry7
10,000 psychologists. One massive conference. And Synapticure on stage.
Last week Dr. Meyers shared our CoCM data at the @APA Annual Conference— showing how we improve quality of life + reduce depression & anxiety for people living with #neurodiseases.
Last week Dr. Meyers shared our CoCM data at the @APA Annual Conference— showing how we improve quality of life + reduce depression & anxiety for people living with #neurodiseases.
August 11, 2025 at 10:22 PM
10,000 psychologists. One massive conference. And Synapticure on stage.
Last week Dr. Meyers shared our CoCM data at the @APA Annual Conference— showing how we improve quality of life + reduce depression & anxiety for people living with #neurodiseases.
Last week Dr. Meyers shared our CoCM data at the @APA Annual Conference— showing how we improve quality of life + reduce depression & anxiety for people living with #neurodiseases.
Meet Dr. Tate, a fellowship-trained movement disorder specialist! She's passionate about patient-centered care, shared decision-making, and in-home neurology care, especially for people living in rural areas (growing up in a rural area herself!)
Learn more vist.ly/32cn8
Learn more vist.ly/32cn8
August 5, 2025 at 4:29 PM
Meet Dr. Tate, a fellowship-trained movement disorder specialist! She's passionate about patient-centered care, shared decision-making, and in-home neurology care, especially for people living in rural areas (growing up in a rural area herself!)
Learn more vist.ly/32cn8
Learn more vist.ly/32cn8
Mark your calendars! Chief Medical Officer Dr. Eric Anderson is speaking at @alsassociation #ALSNexus conference, joining a powerful conversation on one of the most over-looked forces in #ALS care: family caregivers.
Learn more: vist.ly/328qz
#Caregivers
Learn more: vist.ly/328qz
#Caregivers
August 4, 2025 at 5:11 PM
Mark your calendars! Chief Medical Officer Dr. Eric Anderson is speaking at @alsassociation #ALSNexus conference, joining a powerful conversation on one of the most over-looked forces in #ALS care: family caregivers.
Learn more: vist.ly/328qz
#Caregivers
Learn more: vist.ly/328qz
#Caregivers
What do you get when you mix bold ideas, neuroscience, and a whole lot of brainpower? A week at #AAIC with our team 😄🧠
We had a blast sharing our work and learning from so many others pushing the boundaries in #Alzheimer’s research and care delivery.
We had a blast sharing our work and learning from so many others pushing the boundaries in #Alzheimer’s research and care delivery.
August 1, 2025 at 4:38 PM
What do you get when you mix bold ideas, neuroscience, and a whole lot of brainpower? A week at #AAIC with our team 😄🧠
We had a blast sharing our work and learning from so many others pushing the boundaries in #Alzheimer’s research and care delivery.
We had a blast sharing our work and learning from so many others pushing the boundaries in #Alzheimer’s research and care delivery.
“I had no knowledge about Alzheimer's or dementia.” Like many caregivers, Sherry felt overwhelmed—until she connected with our expert team through Senior Helpers.
You don’t need to be an expert. You just need a care partner who is
Learn more at synapticure.com or (855) 255-5917
You don’t need to be an expert. You just need a care partner who is
Learn more at synapticure.com or (855) 255-5917
July 31, 2025 at 4:28 PM
“I had no knowledge about Alzheimer's or dementia.” Like many caregivers, Sherry felt overwhelmed—until she connected with our expert team through Senior Helpers.
You don’t need to be an expert. You just need a care partner who is
Learn more at synapticure.com or (855) 255-5917
You don’t need to be an expert. You just need a care partner who is
Learn more at synapticure.com or (855) 255-5917
We’re thrilled to share that Synapticure was awarded the Hoffman ALS Clinic Capacity Award by the @alsassociation to expand access to expert, multidisciplinary ALS care through telemedicine.
Read the release: vist.ly/3zkur
#EndALS #ALSCare #Telehealth #VirtualCare
Read the release: vist.ly/3zkur
#EndALS #ALSCare #Telehealth #VirtualCare
The ALS Association Awards 8 Hoffman ALS Clinic Development & Capacity Awards to Expand Access to Life-Enhancing Multidisciplinary ALS Care
/PRNewswire/ -- The ALS Association announced inaugural recipients of the Hoffman ALS Clinic Development and Capacity Awards, new grant programs established to...
www.prnewswire.com
July 30, 2025 at 12:24 AM
We’re thrilled to share that Synapticure was awarded the Hoffman ALS Clinic Capacity Award by the @alsassociation to expand access to expert, multidisciplinary ALS care through telemedicine.
Read the release: vist.ly/3zkur
#EndALS #ALSCare #Telehealth #VirtualCare
Read the release: vist.ly/3zkur
#EndALS #ALSCare #Telehealth #VirtualCare
🧵 A new study shows that dogs may be able to sniff out Parkinson’s disease— even before symptoms appear.
vist.ly/3zg34
This breakthrough could open new doors for early detection and intervention.
#Parkinsons #PD #Research #PDNews
vist.ly/3zg34
This breakthrough could open new doors for early detection and intervention.
#Parkinsons #PD #Research #PDNews
July 28, 2025 at 6:44 PM
🧵 A new study shows that dogs may be able to sniff out Parkinson’s disease— even before symptoms appear.
vist.ly/3zg34
This breakthrough could open new doors for early detection and intervention.
#Parkinsons #PD #Research #PDNews
vist.ly/3zg34
This breakthrough could open new doors for early detection and intervention.
#Parkinsons #PD #Research #PDNews
What’s the difference between #Alzheimer’s and #dementia? 🧠 It’s not just semantics—understanding the difference can lead to better care and earlier support.
Looking for support? Visit synapticure.com or call (855) 255-5917
#AlzheimersAwareness
Looking for support? Visit synapticure.com or call (855) 255-5917
#AlzheimersAwareness
July 25, 2025 at 6:26 PM
What’s the difference between #Alzheimer’s and #dementia? 🧠 It’s not just semantics—understanding the difference can lead to better care and earlier support.
Looking for support? Visit synapticure.com or call (855) 255-5917
#AlzheimersAwareness
Looking for support? Visit synapticure.com or call (855) 255-5917
#AlzheimersAwareness
🤝 Our work is built to accelerate yours. Whether you're testing a therapeutic hypothesis, running phenotypic screens, or developing patient-relevant models, our team supports:
✔ Target discovery and validation
✔ Compound screening
✔ Model customization
✔ Target discovery and validation
✔ Compound screening
✔ Model customization
July 25, 2025 at 10:00 AM
🤝 Our work is built to accelerate yours. Whether you're testing a therapeutic hypothesis, running phenotypic screens, or developing patient-relevant models, our team supports:
✔ Target discovery and validation
✔ Compound screening
✔ Model customization
✔ Target discovery and validation
✔ Compound screening
✔ Model customization
Ozzy Osbourne wasn’t just the Prince of Darkness— he was a global icon who helped shine a light on the reality of #Parkinsons
As we honor his legacy, we’re reminded of the millions living with #PD and the urgent need for expert care & continued research
vist.ly/3yxi6
As we honor his legacy, we’re reminded of the millions living with #PD and the urgent need for expert care & continued research
vist.ly/3yxi6
Ozzy Osbourne’s Death Puts Spotlight on Parkinson’s Disease
Ozzy Osbourne, lead singer of Black Sabbath, has died at age 76. He said he had been previously diagnosed with a form of Parkinson’s disease linked to the gene PRKN
www.scientificamerican.com
July 23, 2025 at 9:11 PM
Ozzy Osbourne wasn’t just the Prince of Darkness— he was a global icon who helped shine a light on the reality of #Parkinsons
As we honor his legacy, we’re reminded of the millions living with #PD and the urgent need for expert care & continued research
vist.ly/3yxi6
As we honor his legacy, we’re reminded of the millions living with #PD and the urgent need for expert care & continued research
vist.ly/3yxi6
A routine appointment. A life-altering diagnosis. Six months to live. This was co-founders Sandra Abrevaya and Brian Wallach's reality, and it ignited their fight for change- So no one faces #ALS, #ALZ, #PD, #HD or related conditions alone.
Learn more ➡️ vist.ly/3yec3
Learn more ➡️ vist.ly/3yec3
July 18, 2025 at 6:35 PM
A routine appointment. A life-altering diagnosis. Six months to live. This was co-founders Sandra Abrevaya and Brian Wallach's reality, and it ignited their fight for change- So no one faces #ALS, #ALZ, #PD, #HD or related conditions alone.
Learn more ➡️ vist.ly/3yec3
Learn more ➡️ vist.ly/3yec3
🧬 The value of our in vitro models lies on how closely they reflect patient biology.
Our unique strength lies in...
Our unique strength lies in...
Granulin loss of function in human mature brain organoids implicates astrocytes in TDP-43 pathology
In this article, de Majo et al. present a novel 3D iPSC-derived model to study neurodegenerativedisorders such as ALS and FTD. When devoid of GRN expression, these cultures presentfeatures of ALS- and FTD-associated pathology hardly ever observed in vitro. Thesephenotypes are shown to be primarily driven by diseased astrocytes and can be rescuedby pro-granulin supplementation.
www.cell.com
July 16, 2025 at 7:40 PM
🧬 The value of our in vitro models lies on how closely they reflect patient biology.
Our unique strength lies in...
Our unique strength lies in...
Ever left a doctor’s appointment feeling rushed, confused, or like your concerns didn’t matter?
Not here. You deserve care that’s thorough, personal, and makes you feel heard 💙
Visit synapticure.com or call (855) 255-5917 to learn more
Not here. You deserve care that’s thorough, personal, and makes you feel heard 💙
Visit synapticure.com or call (855) 255-5917 to learn more
July 14, 2025 at 9:18 PM
Ever left a doctor’s appointment feeling rushed, confused, or like your concerns didn’t matter?
Not here. You deserve care that’s thorough, personal, and makes you feel heard 💙
Visit synapticure.com or call (855) 255-5917 to learn more
Not here. You deserve care that’s thorough, personal, and makes you feel heard 💙
Visit synapticure.com or call (855) 255-5917 to learn more
Celebrating the 4th of July while caring for someone with dementia? Here are 5 tips from our experts to help you navigate the day with calm, comfort, and connection 💙
#Dementia #DementiaTips #CaregiverTips #DementiaCaregiver #Alzheimers #CaregiverResources #IndependenceDay #FourthofJuly
#Dementia #DementiaTips #CaregiverTips #DementiaCaregiver #Alzheimers #CaregiverResources #IndependenceDay #FourthofJuly
July 2, 2025 at 6:15 PM
Celebrating the 4th of July while caring for someone with dementia? Here are 5 tips from our experts to help you navigate the day with calm, comfort, and connection 💙
#Dementia #DementiaTips #CaregiverTips #DementiaCaregiver #Alzheimers #CaregiverResources #IndependenceDay #FourthofJuly
#Dementia #DementiaTips #CaregiverTips #DementiaCaregiver #Alzheimers #CaregiverResources #IndependenceDay #FourthofJuly
Big news: @Synapticure’s R&D team was just awarded a $2.5M SBIR grant from the @National Institute of Neurological Disorders and Stroke to expand our laboratory research!
➡️ vist.ly/3n623ud
➡️ vist.ly/3n623ud
June 16, 2025 at 12:00 PM
Big news: @Synapticure’s R&D team was just awarded a $2.5M SBIR grant from the @National Institute of Neurological Disorders and Stroke to expand our laboratory research!
➡️ vist.ly/3n623ud
➡️ vist.ly/3n623ud
With Synapticure you’re never alone. We make sure you receive the right care & support, when and where you need it most.
Learn more ➡️ Visit synapticure.com or call (855) 255-5917.
#VirtualCare #Dementia #ALS #ALZ #PD #HD #Caregiver #CaregiverResources
Learn more ➡️ Visit synapticure.com or call (855) 255-5917.
#VirtualCare #Dementia #ALS #ALZ #PD #HD #Caregiver #CaregiverResources
June 13, 2025 at 6:30 PM
With Synapticure you’re never alone. We make sure you receive the right care & support, when and where you need it most.
Learn more ➡️ Visit synapticure.com or call (855) 255-5917.
#VirtualCare #Dementia #ALS #ALZ #PD #HD #Caregiver #CaregiverResources
Learn more ➡️ Visit synapticure.com or call (855) 255-5917.
#VirtualCare #Dementia #ALS #ALZ #PD #HD #Caregiver #CaregiverResources